Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
2008

Pioglitazone's Role in Protecting Neurons from Inflammation

Sample size: 3 publication Evidence: high

Author Information

Author(s): Xing Bin, Xin Tao, Hunter Randy Lee, Bing Guoying

Primary Institution: University of Kentucky

Hypothesis

Does pioglitazone inhibit nitric oxide synthase activity and protect dopaminergic neurons from lipopolysaccharide-induced damage?

Conclusion

Pioglitazone protects dopaminergic neurons from inflammation by inhibiting nitric oxide production and iNOS expression, potentially through the p38 MAPK and PI3K pathways.

Supporting Evidence

  • Pioglitazone significantly reduced LPS-induced NO production by 40% to 60%.
  • Inhibition of iNOS expression was observed with pioglitazone treatment.
  • Pretreatment with pioglitazone inhibited LPS-induced phosphorylation of p38 MAPK.

Takeaway

Pioglitazone helps protect brain cells from damage caused by inflammation by stopping the production of harmful substances.

Methodology

The study used neuron-microglia mixed cultures treated with pioglitazone and/or LPS, measuring iNOS levels and NO production through western blot and nitrite assays.

Participant Demographics

Timed-pregnant Sprague Dawley rats were used for the experiments.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1742-2094-5-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication